glp 1/gip agonist New strategies for the treatment of obesity and metabolic dysfunctions Frontiers | Clinical perspectives on
Description
Glucagon-like peptide-1 (GLP-1) is a hormone produced by the stomach in response to food, which plays an important role in regulating appetite and blood sugar levels
These agents appear to modulate brain regions implicated in addiction, thereby reducing alcohol cravings and consumption, particularly among individuals with obesity [19, 20]
Diabetes Investig
Weight change after diagnosis, obesity at diagnosis, and diabetes have all been linked to worse cancer outcomes in earlier work
Quality Assessment The results of the quality assessment were visualized using R and the robvis tool (Fig
